Teewinot Capital Advisers, L.L.C. Eli Lilly & CO Transaction History
Teewinot Capital Advisers, L.L.C.
- $1.01 Billion
- Q2 2024
A detailed history of Teewinot Capital Advisers, L.L.C. transactions in Eli Lilly & CO stock. As of the latest transaction made, Teewinot Capital Advisers, L.L.C. holds 87,058 shares of LLY stock, worth $76.4 Million. This represents 7.77% of its overall portfolio holdings.
Number of Shares
87,058
Previous 88,106
1.19%
Holding current value
$76.4 Million
Previous $68.5 Million
15.0%
% of portfolio
7.77%
Previous 7.19%
Shares
8 transactions
Others Institutions Holding LLY
# of Institutions
3,872Shares Held
751MCall Options Held
6.34MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$85.4 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$64.8 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$57.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$45.1 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$29.7 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $834B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...